SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-124381
Filing Date
2023-04-28
Accepted
2023-04-28 08:01:55
Documents
13
Period of Report
2023-04-24
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d452268d8k.htm   iXBRL 8-K 28672
2 EX-3.1 d452268dex31.htm EX-3.1 173307
  Complete submission text file 0001193125-23-124381.txt   360673

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA pmvp-20230424.xsd EX-101.SCH 2844
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE pmvp-20230424_lab.xml EX-101.LAB 17980
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pmvp-20230424_pre.xml EX-101.PRE 11254
7 EXTRACTED XBRL INSTANCE DOCUMENT d452268d8k_htm.xml XML 3435
Mailing Address 8 CLARKE DRIVE CRANBURY NJ 08512
Business Address 8 CLARKE DRIVE CRANBURY NJ 08512 (609) 642-6664
PMV Pharmaceuticals, Inc. (Filer) CIK: 0001699382 (see all company filings)

IRS No.: 463218129 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39539 | Film No.: 23860271
SIC: 2834 Pharmaceutical Preparations